June 2023
1. PITTOCK SJ, Barnett M, Bennett JL, Berthele A, et al
   Ravulizumab in Aquaporin-4-Positive Neuromyelitis Optica Spectrum Disorder.
   Ann Neurol. 2023;93:1053-1068.
   

   >> Share

   
   
2. YIN HX, Wang YJ, Liu MG, Zhang DD, et al
   Aquaporin-4 Antibody Dynamics and Relapse Risk in Seropositive Neuromyelitis Optica Spectrum Disorder Treated with Immunosuppressants.
   Ann Neurol. 2023;93:1069-1081.
   

   >> Share

   
   May 2023
3. HOLM HANSEN R, von Essen MR, Mahler MR, Cobanovic S, et al
   Cladribine effects on T and B cells and T cell reactivity in multiple sclerosis.
   Ann Neurol. 2023 May 16. doi: 10.1002/ana.26684.
   

   >> Share

   
   
4. PATRICK MT, Nair RP, He K, Stuart PE, et al
   Shared Genetic Risk Factors for Multiple Sclerosis/Psoriasis Suggest Involvement of Interleukin-17 and Janus Kinase-Signal Transducers and Activators of Transcription Signaling.
   Ann Neurol. 2023 May 1. doi: 10.1002/ana.26672.
   

   >> Share

   
   April 2023
5. HAMZAOUI M, Garcia J, Boffa G, Lazzarotto A, et al
   Positron emission tomography with [(18) F]-DPA-714 unveils a smoldering component in most multiple sclerosis lesions which drives disease progression.
   Ann Neurol. 2023 Apr 11. doi: 10.1002/ana.26657.
   

   >> Share

   
   March 2023
6. BAKIRTZIS C, Langdon DW, Grigoriadis N
   Time to rebaseline cognitive performance in people with multiple sclerosis?
   Ann Neurol. 2023 Mar 8. doi: 10.1002/ana.26628.
   

   >> Share

   
   
7. GALARDI MM, Sowa GM, Crockett CD, Rudock R, et al
   Pathogen and Antibody Identification in Children with Encephalitis in Myanmar.
   Ann Neurol. 2023;93:615-628.
   

   >> Share

   
   February 2023
8. KALLURI HV, Rosebraugh MR, Misko TP, Ziemann A, et al
   Phase 1 Evaluation of Elezanumab (Anti-Repulsive Guidance Molecule A Monoclonal Antibody) in Healthy and Multiple Sclerosis Participants.
   Ann Neurol. 2023;93:285-296.
   

   >> Share

   
   January 2023
9. SALVARANI C, Paludo J, Hunder GG, Ansell SM, et al
   Exploring Gene Expression Profiles in Primary Central Nervous System Vasculitis.
   Ann Neurol. 2023;93:120-130.
   

   >> Share

   
   
10. STREDNY CM, Blessing MM, Yi V, Ryan ME, et al
    Mimics of Pediatric Small Vessel Primary Angiitis of the Central Nervous System.
    Ann Neurol. 2023;93:109-119.
    

    >> Share

    
    December 2022
11. PAYET CA, You A, Fayet OM, Hemery E, et al
    Central role of macrophages and nucleic acid release in Myasthenia Gravis thymus.
    Ann Neurol. 2022 Dec 26. doi: 10.1002/ana.26590.
    

    >> Share

    
    
12. VAN DEN BOSCH AMR, Hummert S, Steyer A, Ruhwedel T, et al
    Ultrastructural Axon-Myelin Unit Alterations in Multiple Sclerosis Correlate with Inflammation.
    Ann Neurol. 2022 Dec 24. doi: 10.1002/ana.26585.
    

    >> Share

    
    
13. ZHANG Y, Zhou Q, Peng L, Chen S, et al
    Increased cerebellum (18) F-DPA-714 uptake in anti-Gluk2-autoimmune encephalitis.
    Ann Neurol. 2022 Dec 8. doi: 10.1002/ana.26563.
    

    >> Share

    
    
14. NGUYEN S, Bastien E, Chretien B, Sassier M, et al
    Transverse Myelitis Following SARS-CoV-2 Vaccination: A Pharmacoepidemiological Study in the World Health Organization's Database.
    Ann Neurol. 2022;92:1080-1089.
    

    >> Share

    
    November 2022
15. OKUDA DT, Kantarci O, Lebrun-Frenay C, Sormani MP, et al
    Dimethyl fumarate delays multiple sclerosis in radiologically isolated syndrome.
    Ann Neurol. 2022 Nov 18. doi: 10.1002/ana.26555.
    

    >> Share

    
    
16. GARCIA-MONTOJO M, Simula ER, Fathi S, McMahan C, et al
    Antibody Response to HML-2 May Be Protective in Amyotrophic Lateral Sclerosis.
    Ann Neurol. 2022;92:782-792.
    

    >> Share

    
    October 2022
17. VAN KEMPEN ZLE, Hogenboom L, Toorop AA, Steenhuis M, et al
    Ocrelizumab concentration is a good predictor of SARS-CoV-2 vaccination response in patients with multiple sclerosis.
    Ann Neurol. 2022 Oct 17. doi: 10.1002/ana.26534.
    

    >> Share

    
    
18. MURPHY OC, Sotirchos ES, Kalaitzidis G, Vasileiou E, et al
    Trans-synaptic degeneration following acute optic neuritis in multiple sclerosis.
    Ann Neurol. 2022 Oct 11. doi: 10.1002/ana.26529.
    

    >> Share

    
    September 2022
19. KELLER CW, Chuquisana O, Derdelinckx J, Gross CC, et al
    Impaired B cell Expression of the Inhibitory Fcgamma Receptor IIB in Myasthenia Gravis.
    Ann Neurol. 2022 Sep 12. doi: 10.1002/ana.26507.
    

    >> Share

    
    
20. GAUDIOSO CM, Mar S, Casper TC, Codden R, et al
    MOG and AQP4 antibodies among children with multiple sclerosis and controls.
    Ann Neurol. 2022 Sep 11. doi: 10.1002/ana.26502.
    

    >> Share

    
    August 2022
21. LINDGREN U, Pullerits R, Lindberg C, Oldfors A, et al
    Epidemiology, Survival, and Clinical Characteristics of Inclusion Body Myositis.
    Ann Neurol. 2022;92:201-212.
    

    >> Share

    
    June 2022
22. MAGLIOZZI R, Fadda G, Brown RA, Bar-Or A, et al
    "Ependymal-in" gradient of thalamic damage in progressive multiple sclerosis.
    Ann Neurol. 2022 Jun 24. doi: 10.1002/ana.26448.
    

    >> Share

    
    
23. RAHMANZADEH R, Galbusera R, Lu PJ, Bahn E, et al
    A new advanced MRI biomarker for remyelinated lesions in Multiple Sclerosis.
    Ann Neurol. 2022 Jun 17. doi: 10.1002/ana.26441.
    

    >> Share

    
    
24. KOIZUMI N, Takasugi J, Ohara N, Kawamoto M, et al
    FDG-PET/CT of Giant Cell Arteritis With Normal Inflammatory Markers.
    Ann Neurol. 2022 Jun 6. doi: 10.1002/ana.26428.
    

    >> Share

    
    
25. OECHTERING J, Lincke T, Schaedelin S, Decard BF, et al
    Intrathecal IgM Synthesis Is Associated with Spinal Cord Manifestation and Neuronal Injury in Early MS.
    Ann Neurol. 2022;91:814-820.
    

    >> Share

    
    May 2022
26. CACCIAGUERRA L, Carotenuto A, Pagani E, Mistri D, et al
    MRI EVALUATION OF PERIVASCULAR SPACE ABNORMALITIES IN NEUROMYELITIS OPTICA.
    Ann Neurol. 2022 May 20. doi: 10.1002/ana.26419.
    

    >> Share

    
    
27. ZEYDAN B, Rocca MA, Kantarci OH, Filippi M, et al
    Spinal Cord Atrophy Is a Preclinical Marker of Progressive MS.
    Ann Neurol. 2022;91:734-735.
    

    >> Share

    
    
28. GHIROTTO B, Oliveira DF, Cipelli M, Basso PJ, et al
    MS-Driven Metabolic Alterations Are Recapitulated in iPSC-Derived Astrocytes.
    Ann Neurol. 2022;91:652-669.
    

    >> Share

    
    
29. DIEBOLD M, Galli E, Kopf A, Sanderson N, et al
    Immunological Predictors of Dimethyl Fumarate-Induced Lymphopenia.
    Ann Neurol. 2022;91:676-681.
    

    >> Share

    
    April 2022
30. MANDEL-BREHM C, Benson LA, Tran B, Kung AF, et al
    ZSCAN1 autoantibodies are associated with pediatric paraneoplastic ROHHAD.
    Ann Neurol. 2022 Apr 25. doi: 10.1002/ana.26380.
    

    >> Share

    
    
31. BOSE G, Healy BC, Lokhande HA, Sotiropoulos MG, et al
    Early predictors of clinical and MRI outcomes using LASSO in multiple sclerosis.
    Ann Neurol. 2022 Apr 15. doi: 10.1002/ana.26370.
    

    >> Share

    
    
32. IWAMOTO S, Itokazu T, Sasaki A, Kataoka H, et al
    RGMa Signal in Macrophages Induces Neutrophil-Related Astrocytopathy in NMO.
    Ann Neurol. 2022;91:532-547.
    

    >> Share

    
    
33. DOETS AY, Walgaard C, Lingsma HF, Islam B, et al
    International Validation of the Erasmus Guillain-Barre Syndrome Respiratory Insufficiency Score.
    Ann Neurol. 2022;91:521-531.
    

    >> Share

    
    March 2022
34. KISTER I, Patskovsky Y, Curtin R, Pei J, et al
    Cellular and humoral immunity to SARS-CoV-2 infection in multiple sclerosis patients on ocrelizumab and other disease-modifying therapies: a multi-ethnic observational study.
    Ann Neurol. 2022 Mar 15. doi: 10.1002/ana.26346.
    

    >> Share

    
    
35. LANGER-GOULD A, Cheng SC, Li BH, Smith JB, et al
    Decreasing Multiple Sclerosis Treatment Expenditures and Improving Quality at the Health System Level.
    Ann Neurol. 2022 Mar 13. doi: 10.1002/ana.26352.
    

    >> Share

    
    
36. BRILL L, Raposo C, Rechtman A, Zveik O, et al
    SARS-CoV-2 third vaccine immune response in MS patients treated with ocrelizumab.
    Ann Neurol. 2022 Mar 4. doi: 10.1002/ana.26343.
    

    >> Share

    
    
37. KORNEK B, Leutmezer F, Rommer PS, Koblischke M, et al
    B Cell Depletion and SARS-CoV-2 Vaccine Responses in Neuroimmunologic Patients.
    Ann Neurol. 2022;91:342-352.
    

    >> Share

    
    February 2022
38. DE MEO E, Filippi M, Trojano M, Comi G, et al
    Comparing natural history of early and late onset pediatric multiple sclerosis.
    Ann Neurol. 2022 Feb 12. doi: 10.1002/ana.26322.
    

    >> Share

    
    
39. ZEKERIDOU A, Yang B, Lennon VA, Guo Y, et al
    Anti-Neuronal Nuclear Antibody 3 Autoimmunity targets Dachshund homolog 1.
    Ann Neurol. 2022 Feb 12. doi: 10.1002/ana.26320.
    

    >> Share

    
    
40. MCCOMBE JA, Flanagan EP, Chen JJ, Zekeridou A, et al
    Investigating the Immunopathogenic Mechanisms Underlying MOGAD.
    Ann Neurol. 2022;91:299-300.
    

    >> Share

    
    January 2022
41. MCKAY KA, Bedri SK, Manouchehrinia A, Stawiarz L, et al
    Reduction in cognitive processing speed surrounding multiple sclerosis relapse.
    Ann Neurol. 2022 Jan 4. doi: 10.1002/ana.26301.
    

    >> Share

    
    December 2021
42. FLEISCHER V, Ciolac D, Gonzalez-Escamilla G, Grothe M, et al
    Subcortical volumes as early predictors of fatigue in multiple sclerosis.
    Ann Neurol. 2021 Dec 30. doi: 10.1002/ana.26290.
    

    >> Share

    
    
43. BISCHOF A, Papinutto N, Keshavan A, Rajesh A, et al
    Spinal cord atrophy predicts progressive disease in relapsing multiple sclerosis.
    Ann Neurol. 2021 Dec 8. doi: 10.1002/ana.26281.
    

    >> Share

    
    
44. HEINE J, Kopp UA, Klag J, Ploner CJ, et al
    Long-Term Cognitive Outcome in Anti-N-Methyl-D-Aspartate Receptor Encephalitis.
    Ann Neurol. 2021;90:949-961.
    

    >> Share

    
    
45. SANTYR B, Pejhan S, Zhang Q, Budhram A, et al
    Unilateral Primary Angiitis of the Central Nervous System.
    Ann Neurol. 2021;90:999-1000.
    

    >> Share

    
    November 2021
46. ZRZAVY T, Endmayr V, Bauer J, Macher S, et al
    Neuropathological Variability within a Spectrum of NMDAR-Encephalitis.
    Ann Neurol. 2021;90:725-737.
    

    >> Share

    
    
47. QUENDT C, Ochs J, Hausser-Kinzel S, Hausler D, et al
    Proinflammatory CD20(+) T Cells are Differentially Affected by Multiple Sclerosis Therapeutics.
    Ann Neurol. 2021;90:834-839.
    

    >> Share

    
    October 2021
48. MARAMATTOM BV, Krishnan P, Paul R, Padmanabhan S, et al
    Reply to 'Adenovirus COVID-19 vaccines and Guillain-Barre syndrome with facial paralysis by Dr Pegat et al.
    Ann Neurol. 2021 Oct 27. doi: 10.1002/ana.26257.
    

    >> Share

    
    
49. PEGAT A, Vogrig A, Khouri C, Masmoudi K, et al
    Adenovirus COVID-19 vaccines and Guillain-Barre syndrome with facial paralysis.
    Ann Neurol. 2021 Oct 26. doi: 10.1002/ana.26258.
    

    >> Share

    
    
50. TALLANTYRE EC, Vickaryous N, Anderson V, Asardag AN, et al
    COVID-19 vaccine response in people with multiple sclerosis.
    Ann Neurol. 2021 Oct 22. doi: 10.1002/ana.26251.
    

    >> Share

    
    September 2021
51. KOCH MW, Kaur S, Sage K, Kim J, et al
    Hydroxychloroquine for Primary Progressive Multiple Sclerosis.
    Ann Neurol. 2021 Sep 30. doi: 10.1002/ana.26239.
    

    >> Share

    
    
52. OSOWICKI J, Morgan H, Harris A, Crawford NW, et al
    Guillain-Barre Syndrome in an Australian state using both mRNA and adenovirus-vector SARS-CoV-2 vaccines.
    Ann Neurol. 2021 Sep 15. doi: 10.1002/ana.26218.
    

    >> Share

    
    
53. ZUHORN F, Graf T, Klingebiel R, Schabitz WR, et al
    Postvaccinal Encephalitis after ChAdOx1 nCov-19.
    Ann Neurol. 2021;90:506-511.
    

    >> Share

    
    August 2021
54. KIMURA K, Lin Y, Yamaguchi H, Sato W, et al
    Th1 - CD11c(+) B cell axis associated with response to plasmapheresis in multiple sclerosis.
    Ann Neurol. 2021 Aug 23. doi: 10.1002/ana.26202.
    

    >> Share

    
    
55. PAN S, Chan JR
    Clinical Applications of Myelin Plasticity for Remyelinating Therapies in Multiple Sclerosis.
    Ann Neurol. 2021 Aug 17. doi: 10.1002/ana.26196.
    

    >> Share

    
    
56. KOLB H, Absinta M, Beck ES, Ha SK, et al
    7T MRI Differetiates Remyelinated from Demyelinated Multiple Sclerosis Lesions.
    Ann Neurol. 2021 Aug 14. doi: 10.1002/ana.26194.
    

    >> Share

    
    
57. TEWKESBURY G, Song JW, Perrone CM
    Magnetic Resonance Imaging of Autoimmune GFAP Astrocytopathy.
    Ann Neurol. 2021 Aug 13. doi: 10.1002/ana.26195.
    

    >> Share

    
    July 2021
58. HANDUNNETTHI L, Knezevic B, Kasela S, Burnham KL, et al
    Genomic insights into myasthenia gravis identify distinct immunological mechanisms in early and late onset disease.
    Ann Neurol. 2021 Jul 19. doi: 10.1002/ana.26169.
    

    >> Share

    
    
59. METZ I, Gavrilova RH, Weigand SD, Frischer JM, et al
    MRI Correlates of Multiple Sclerosis Immunopathological Patterns.
    Ann Neurol. 2021 Jul 7. doi: 10.1002/ana.26163.
    

    >> Share

    
    
60. GELIBTER S, Pisa M, Croese T, Finardi A, et al
    Spinal fluid myeloid microvesicles predict disease course in multiple sclerosis.
    Ann Neurol. 2021 Jul 3. doi: 10.1002/ana.26154.
    

    >> Share

    
    
61. HAUSER SL
    Curing Multiple Sclerosis: How to Know When We're There?
    Ann Neurol. 2021 Jul 2. doi: 10.1002/ana.26155.
    

    >> Share

    
    June 2021
62. ALLEN CM, Ramsamy S, Tarr AW, Tighe PJ, et al
    Guillain-Barre syndrome variant occurring after SARS-CoV-2 vaccination.
    Ann Neurol. 2021 Jun 10. doi: 10.1002/ana.26144.
    

    >> Share

    
    
63. MARAMMATOM BV, Krishnan P, Paul R, Padmanabhan S, et al
    Guillain-Barre syndrome following ChAdOx1-S/nCoV-19 vaccine.
    Ann Neurol. 2021 Jun 10. doi: 10.1002/ana.26143.
    

    >> Share

    
    
64. HARTUNG HP
    Neuromyelitis Optica Spectrum Disorder: Therapeutic Innovations and Complex Decision-Making.
    Ann Neurol. 2021;89:1084-1087.
    

    >> Share

    
    
65. WINGERCHUK DM, Fujihara K, Palace J, Berthele A, et al
    Long-Term Safety and Efficacy of Eculizumab in Aquaporin-4 IgG-Positive NMOSD.
    Ann Neurol. 2021;89:1088-1098.
    

    >> Share

    
    May 2021
66. OECHTERING J, Schaedelin S, Benkert P, Muller S, et al
    Intrathecal Immunoglobulin M synthesis is an independent biomarker for higher disease activity and severity in multiple sclerosis.
    Ann Neurol. 2021 May 31. doi: 10.1002/ana.26137.
    

    >> Share

    
    
67. BEUKER C, Wankner MC, Thomas C, Strecker JK, et al
    Characterization of extracranial giant cell arteritis with intracranial involvement and its rapidly progressive subtype.
    Ann Neurol. 2021 May 16. doi: 10.1002/ana.26101.
    

    >> Share

    
    
68. LANDA J, Guasp M, Miguez-Cabello F, Guimaraes J, et al
    Encephalitis with autoantibodies against the glutamate kainate receptors GluK2.
    Ann Neurol. 2021 May 5. doi: 10.1002/ana.26098.
    

    >> Share

    
    
69. AKTAS O, Smith MA, Rees WA, Bennett JL, et al
    Serum Glial Fibrillary Acidic Protein: A Neuromyelitis Optica Spectrum Disorder Biomarker.
    Ann Neurol. 2021;89:895-910.
    

    >> Share

    
    April 2021
70. IZUKA S, Kobayashi T, Takahashi Y
    Tongue tremor in systemic lupus erythematosus.
    Ann Neurol. 2021 Apr 21. doi: 10.1002/ana.26088.
    

    >> Share

    
    
71. COX LM, Maghzi AH, Liu S, Tankou SK, et al
    The Gut Microbiome in Progressive Multiple Sclerosis.
    Ann Neurol. 2021 Apr 19. doi: 10.1002/ana.26084.
    

    >> Share

    
    
72. PETZOLD A
    Reply to "Peripapillary Hyper-Reflective Ovoid Masslike Structures in Astronauts".
    Ann Neurol. 2021;89:849-850.
    

    >> Share

    
    
73. WOSTYN P, Gibson CR, Mader TH
    Peripapillary Hyper-Reflective Ovoid Mass-Like Structures in Astronauts.
    Ann Neurol. 2021;89:849.
    

    >> Share

    
    
74. LUCHICCHI A, Hart B, Frigerio I, van Dam AM, et al
    Axon-Myelin Unit Blistering as Early Event in MS Normal Appearing White Matter.
    Ann Neurol. 2021;89:711-725.
    

    >> Share

    
    January 2021
75. DE BRUIJN MAAM, Bastiaansen AEM, Mojzisova H, van Sonderen A, et al
    The Antibodies Contributing to focal Epilepsy Signs and symptoms (ACES) score.
    Ann Neurol. 2021 Jan 11. doi: 10.1002/ana.26013.
    

    >> Share

    
    

Free Medical Abstracts
Privacy Policy
Sponsors
Share